Electrospun Poly(lactide-co-glycolide-co-ε-caprolactone) as a Bioresorbable Platform for Docetaxel-Degradation, Drug Delivery Study and Anticancer Activity
- 1Centre of Polymer and Carbon Materials, Polish Academy of Sciences, M. Curie-Skłodowskiej 34, 41-819 Zabrze, Poland
- 2Department of Biopharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Jedności 8, 41-200 Sosnowiec, Poland
- 3Scientific Research Facility, Branch in Bielsko-Biala, Medical University of Silesia, 40-055 Katowice, Poland
Abstract
Drug delivery systems are constantly being developed or modified to meet various requirements, but most of all, they are designed to provide controlled, sustained, and targeted drug delivery. A popular technique of the last few years involves the encapsulation of drugs into polymeric nanofibers with the use of electrospinning. The parameters of the process strongly influence not only the morphology of the fibers but the properties of the whole electrospun system, including the drug release profile. In this study, poly(lactide-co-glycolide-co-ε-caprolactone) and docetaxel were used for the electrospinning process in combination with different kinds of solvents to obtain implantable drug delivery systems. We examined the drug release profile, anticancer activity and course of the nonwoven degradation. As a result, a docetaxel-loaded electrospun terpolymer platform was developed as a drug delivery system intended for potential, loco-regional application in prostate cancer therapy. We observed that the drug release profile of the system prepared using hexafluoroisopropanol differed from the system prepared using dichloromethane, although nearly 100% of the docetaxel was released within 20 weeks in both cases. By contrast, the courses of degradation were similar, except during the last period. Drug-loaded electrospun systems exerted a strong cytotoxic effect on DU-145 and PC-3 prostate cancer cell lines. The flexibility of the system, arising from its fibrous structure, and the anticancer activity observed in vitro provide a basis for further in vivo studies, assessing its suitability as an implantable platform for local drug delivery at the site of tumor growth.
Related
- Targeted Protein Degradation-mediated Regulation of Tumor Angiogenesis for Anticancer Therapy
- In Vitro Anticancer Activity and Integrated Multi-Target Computational Analysis of Ylang-Ylang Essential Oil Against Breast Cancer
- Natural Products in Anticancer Activity: 2nd Edition—From Chemical Diversity to Mechanistic and Translational Insights
- Alkaloids Reported in the Genus Griffinia (Amaryllidaceae): Phytochemical Evidence and Current Limitations in Anticancer Interpretation
- Nucleotide excision repair in tumor response to DNA-damaging anticancer therapies: a comprehensive review.
BibTeX
@article{jaworska2026electrospun,
title = {{Electrospun Poly(lactide-co-glycolide-co-ε-caprolactone) as a Bioresorbable Platform for Docetaxel-Degradation, Drug Delivery Study and Anticancer Activity}},
author = {Joanna Jaworska and Arkadiusz Orchel and Anna Kaps and Marzena Jaworska-Kik and Mateusz Stojko and Monika Musiał-Kulik and Bożena Kaczmarczyk and Małgorzata Pastusiak and Janusz Kasperczyk},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27219789},
url = {https://www.mdpi.com/1422-0067/27/21/9789},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Electrospun Poly(lactide-co-glycolide-co-ε-caprolactone) as a Bioresorbable Platform for Docetaxel-Degradation, Drug Delivery Study and Anticancer Activity
AU - Joanna Jaworska
AU - Arkadiusz Orchel
AU - Anna Kaps
AU - Marzena Jaworska-Kik
AU - Mateusz Stojko
AU - Monika Musiał-Kulik
AU - Bożena Kaczmarczyk
AU - Małgorzata Pastusiak
AU - Janusz Kasperczyk
PY - 2026
DA - 2026/10/31
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27219789
UR - https://www.mdpi.com/1422-0067/27/21/9789
AB - Drug delivery systems are constantly being developed or modified to meet various requirements, but most of all, they are designed to provide controlled, sustained, and targeted drug delivery. A popular technique of the last few years involves the encapsulation of drugs into polymeric nanofibers with the use of electrospinning. The parameters of the process strongly influence not only the morphology of the fibers but the properties of the whole electrospun system, including the drug release profile. In this study, poly(lactide-co-glycolide-co-ε-caprolactone) and docetaxel were used for the electrospinning process in combination with different kinds of solvents to obtain implantable drug delivery systems. We examined the drug release profile, anticancer activity and course of the nonwoven degradation. As a result, a docetaxel-loaded electrospun terpolymer platform was developed as a drug delivery system intended for potential, loco-regional application in prostate cancer therapy. We observed that the drug release profile of the system prepared using hexafluoroisopropanol differed from the system prepared using dichloromethane, although nearly 100% of the docetaxel was released within 20 weeks in both cases. By contrast, the courses of degradation were similar, except during the last period. Drug-loaded electrospun systems exerted a strong cytotoxic effect on DU-145 and PC-3 prostate cancer cell lines. The flexibility of the system, arising from its fibrous structure, and the anticancer activity observed in vitro provide a basis for further in vivo studies, assessing its suitability as an implantable platform for local drug delivery at the site of tumor growth.
SN - 1422-0067
ER -